HIMS News

Pomerantz LLP Advises of Securities Class Action Involving Hims & Hers Health, Inc. – HIMS

ROSEN, A LONGSTANDING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS

Kaplan Fox Announces the Lead Plaintiff Deadline of November 2, 2026 in the Securities Class Action Against Hims & Hers Health, Inc. (HIMS) Ready to Announce with Confidence?

Bragar Eagel & Squire, P.C. Reminds Hims & Hers Health, Inc. Investors of the Upcoming Lead Plaintiff Deadline and Urges Investors to Contact the Firm

HIMS Shareholder Alert: Investigation of Potential Fiduciary Duty Breaches by Hims & Hers Officers and Directors - Kehoe Law Firm, P.C.

HIMS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

Kaplan Fox Notifies Hims & Hers Health, Inc. (NYSE: HIMS) Investors of an Upcoming Lead Plaintiff Deadline on November 2, 2026

HIMS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Hims Investors of Securities Class Action Lawsuit Deadline on November 2, 2026 Ready to Announce with Confidence?

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC

Pomerantz LLP Advises of Securities Class Action Involving Hims & Hers Health, Inc. – HIMS